Savvy Update, 3/27/23: Non-Invasive Monitoring: Know Labs & Hagar’s GWave, California’s Brand of Insulin, Steatosis in Adult T1Ds, MDs Leaving Their Jobs, Colorectal Cancers in Adult T1Ds, Off-Label Prescribing
Know Labs establishes scientific advisory board to advance non-invasive glucose monitoring by Sean Whooley for DrugDeliveryBusiness.com, 22 March 2023. Know Labs announced that it established a scientific advisory board to accelerate the development of its glucose...
Savvy on Gut Microbiome and Type 1 Diabetes, 3/24/23
Today’s post focuses on the gut microbiome and how it impacts management of Type 1 Diabetes The incidence of autoimmune type 1 diabetes (T1D) is increasing worldwide and disease onset tends to occur at a younger age. Unfortunately, clinical trials aiming to...
Savvy Updates, 3/20/23: Vertex Cleared for VX-264 Trials, Nemaura Medical & SugarBeat, Insulin Leads to Smaller Pancreas, Insulet Joins S&P500, Insulin Costs & Price Cuts, Sanofi Buys ProventionBio
New Vertex Type 1 Stem Cell Therapy Gets FDA Nod to Enter Clinical Trials by Andrew Briskin for diaTribe.org, 9 March 2023. The FDA announced that a new type 1 diabetes stem cell therapy from Vertex has been cleared to enter clinical trials in the United...
Savvy Updates, 3/13/23: Abbott Libre 2 & 3 Gets FDA Clearance for AIDs, Bigfoot Biomedical OK’d for Android, The COST of Insulin
Abbott CGMs cleared to integrate with automated insulin delivery systems by Elise Reuter for MedTechDive.com, 6 March 2023. Automated insulin delivery (AID) systems include an insulin pump that communicates with a continuous glucose monitor, which can adjust the...
Savvy Updates, 3/6/23: Lilly Insulin Price Cuts, Erythritol & Heart Risk, iCare, Bigfoot Unity, Fully Closed-Loops
Eli Lilly to Cut Price of Insulin by 70%, Cap Insulin Costs at $35 a Month by Susannah Chen and Natalie Sainz for diaTribe.org, 1 March 2023. Eli Lilly announced that it will cut the list prices for its most commonly prescribed insulins by 70%. The drug...
More Diabetes Blogs